Variables | All groups | NC | AD | −APOEε4 | +APOEε4 |
---|
MMSE (score) | ns | ns | ns | − 0.499** | ns |
AQT (score) | ns | ns | ns | 0.438* | ns |
CRP (mg/l) | ns | ns | ns | 0.534** | ns |
CSF Aβ40 (pg/ml) | − 0.246* | ns | ns | − 0.390* | ns |
CSF Aβ42 (pg/ml) | − 0.349** | − 0.393* | ns | − 0.582*** | ns |
CSF Aβ42/40 | − 0.268* | ns | ns | − 0.472** | ns |
- Data were analysed using Spearman’s correlation test
- Aβ amyloid beta, AD Alzheimer’s disease, APOE4 apolipoprotein 4, −APOEε4 APOEε4 non-carrier, +APOEε4 APOEε4 carrier, AQT A Quick Test, CRP C-reactive protein, CSF cerebrospinal fluid, MMSE Mini-Mental State Examination, NC non-demented control, ns not significant
- *Significant correlation at p ≤ 0.05 level
- **Significant correlation at p ≤ 0.01 level
- ***Significant correlation at p ≤ 0.001 level